Townsend & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.33M | Buy |
48,133
+791
| +2% | +$38.3K | 0.23% | 49 |
|
|
2025
Q1 | $2.32M | Buy |
47,342
+2,817
| +6% | +$138K | 0.24% | 48 |
|
|
2024
Q4 | $2.54M | Sell |
44,525
-124
| -0.3% | -$7.07K | 0.26% | 49 |
|
|
2024
Q3 | $2.37M | Buy |
44,649
+1,051
| +2% | +$55.8K | 0.24% | 49 |
|
|
2024
Q2 | $2.2M | Buy |
43,598
+472
| +1% | +$23.8K | 0.24% | 48 |
|
|
2024
Q1 | $2.11M | Buy |
43,126
+3,070
| +8% | +$150K | 0.25% | 48 |
|
|
2023
Q4 | $2.01M | Sell |
40,056
-2,154
| -5% | -$108K | 0.25% | 48 |
|
|
2023
Q3 | $2.15M | Sell |
42,210
-1,640
| -4% | -$83.7K | 0.45% | 46 |
|
|
2023
Q2 | $2.8M | Sell |
43,850
-252
| -0.6% | -$16.1K | 0.72% | 45 |
|
|
2023
Q1 | $2.94M | Buy |
44,102
+17,422
| +65% | +$1.16M | 1.18% | 30 |
|
|
2022
Q4 | $1.95M | Buy |
26,680
+5,364
| +25% | +$392K | 0.97% | 39 |
|
|
2022
Q3 | $1.71M | Buy |
21,316
+3,934
| +23% | +$315K | 0.79% | 45 |
|
|
2022
Q2 | $1.31M | Buy |
+17,382
| New | +$1.31M | 0.61% | 58 |
|